Have your own idea? Try our Stock Screener
UPDATED Apr 25, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
EBS | US$5.49 | 18.8% | 185.9% | US$291.8m | US$13.50 | PB0.6x | E151.4% | n/a | ||
AZTA | US$26.73 | 5.9% | -48.8% | US$1.2b | US$51.60 | PS1.8x | E127.7% | 0% | ||
PCRX | US$25.72 | 4.3% | -2.3% | US$1.2b | US$36.00 | PS1.7x | E127.5% | n/a | ||
AMRX | US$7.48 | 1.6% | 27.4% | US$2.3b | US$11.67 | PE-20.1x | E127.2% | 0% | ||
PRPH | US$0.37 | 28.0% | -92.2% | US$14.0m | US$13.80 | PS2.3x | E123.2% | 0% | ||
MLAB | US$116.48 | 4.0% | 12.9% | US$632.0m | US$141.67 | PS2.7x | E121.2% | 0.5% | ||
ALVO | US$7.94 | -4.2% | -43.9% | US$2.5b | US$18.00 | PS4.9x | E106.3% | n/a | ||
YCBD | US$0.26 | 14.3% | -69.8% | US$1.6m | US$2.00 | PB0.9x | E95.3% | n/a | ||
EVOK | US$2.58 | 20.0% | -53.1% | US$5.4m | US$18.00 | PB0.8x | E94.0% | n/a | ||
PLX | US$2.85 | 9.2% | 147.8% | US$229.4m | US$14.50 | PE75.9x | E93.0% | n/a | ||
TLRY | US$0.49 | 8.2% | -72.6% | US$490.8m | US$1.31 | PB0.2x | E90.0% | n/a | ||
EXAS | US$45.46 | 9.3% | -22.8% | US$8.5b | US$66.89 | PS3.1x | E86.8% | n/a | ||
NTRB | US$5.32 | 5.3% | 49.9% | US$59.1m | US$13.00 | PS29.2x | E85.4% | n/a | ||
BHC | US$5.44 | 6.7% | -37.5% | US$2.0b | US$8.25 | PE-43.7x | E83.1% | n/a | ||
BNGO | US$4.30 | 6.2% | -90.9% | US$12.8m | US$7.00 | PB0.4x | E81.8% | n/a | ||
VTRS | US$8.13 | 7.5% | -29.7% | US$9.6b | US$11.75 | PB0.5x | E81.7% | 5.9% | ||
IPA | US$0.45 | 2.8% | -65.9% | US$21.2m | US$4.00 | PS1.2x | E79.9% | n/a | ||
AYTU | US$1.11 | 9.9% | -61.8% | US$6.5m | US$8.00 | PB0.2x | E76.8% | n/a | ||
MDXH | US$1.76 | 10.0% | -28.7% | US$85.6m | US$6.04 | PB5.9x | E76.4% | n/a | ||
BIO | US$242.63 | 1.9% | -12.1% | US$6.9b | US$353.17 | PS2.6x | E74.6% | n/a | ||
ENSC | US$3.29 | 86.9% | -62.5% | US$4.7m | US$26.23 | PB1.2x | E74.0% | n/a | ||
HROW | US$25.55 | 6.5% | 142.6% | US$893.9m | US$57.44 | PS4.6x | E73.9% | n/a | ||
ORGO | US$4.56 | 8.1% | 94.0% | US$574.5m | US$6.00 | PS1.2x | E73.3% | n/a | ||
IGC | US$0.30 | 5.4% | -34.7% | US$25.0m | US$3.88 | PS19.3x | E72.8% | n/a |